openalexFrontiers in Endocrinology2026-07-24
Incretin analogues as cardiovascular agents: a state-of-the-art review
Diego Araiza-Garaygordobil, Jorge Rico-Fontalvo, Betsabe Hernández-Balbuena, Monica Vinay-Coro, Mauricio Gonzalez-Arias
Glucagon-like peptide-1 (GLP-1) receptor agonists and the dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist tirzepatide have evolved over the past decade from glucose-lowering antidiabetic agents into a cardiovascular drug class with proven outcom…